F.D.A. Panel Greenlights Moderna Boosters for High-Risk Individualsnews2021-10-14T20:51:21+00:00October 14th, 2021|The New York Times|
Where Things Stand on Boosters for Three Vaccines in the U.S.news2021-10-14T19:36:30+00:00October 14th, 2021|The New York Times|
Merck Asks F.D.A. for Emergency Approval of Covid Pillnews2021-10-12T04:25:38+00:00October 12th, 2021|The New York Times|
Pfizer Asks F.D.A. to Authorize Its Covid-19 Vaccine for Children 5 to 11news2021-10-08T00:24:12+00:00October 8th, 2021|The New York Times|
Johnson & Johnson to Seek F.D.A. Authorization for Booster Shotnews2021-10-04T17:16:18+00:00October 4th, 2021|The New York Times|
La píldora contra la covid: así es como funcionanews2021-10-04T17:14:20+00:00October 4th, 2021|The New York Times|
Merck Says Its Antiviral Pill Is Effective Against Covidnews2021-10-02T01:28:38+00:00October 2nd, 2021|The New York Times|
Was the Decision on Boosters Bungled?news2021-10-01T23:49:07+00:00October 1st, 2021|The New York Times|
Merck’s Covid Treatment Pill: What to Know About Molnupiravirnews2021-10-01T20:06:31+00:00October 1st, 2021|The New York Times|
La desinformación sobre la covid genera la escasez de ivermectina, un medicamento para animalesnews2021-09-30T15:36:21+00:00September 30th, 2021|The New York Times|
